Public authority · Belgium
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track FAMHP in PolicySpeak: request access →
Work at FAMHP? so we know who speaks for it.
FAMHP filed 2 positions between 27 Apr 2021 and 23 Jan 2026, across 2 of the 673 legislative files tracked here, attaching a full position paper 2 times.
Feedback from the Belgian Federal Agency for medicines and health products (famhp) on the combined evaluation roadmap / inception impact assessment of the general pharmaceutical legislation We generally agree with the definition of problems to tackle. However, we note that the revision of the pharmaceutical legislation will only partially tackle the first two issues that are listed.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The Federal Agency for Medicines and Health Products (FAMHP) thanks the Commission for the opportunity to react to this Commission implementing regulation laying down certain uniform quality management and procedural requirements for the conformity assessment activities carried out by a notified body. You will find in attachment some comments on the draft text.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put FAMHP next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Everything on this page comes from FAMHP’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.